Two Ideas Moving Forward.............I am looking at two different possiblities for the main diamond prospect (BK16) moving forward:
1. As Lucara is already a shareholder, Tsodilo partners with Lucara for $5M to execute the bulk sample of BK16. I personally question Lucara and how they continued to have the dividend extend for so long knowing they needed the resources moving forward for the advancement of the UG works. Most likely pushed by Lundin who holds the most shares but not very business wise for the UG advancement.
2. The second would be for EHR Resources to take stake in BK16 bulk sampling. The 5M cost of the bulk sample is right in their ball park for an early exploratin opportunity.
I believe Lucara has first right of refusal but EHR may force them to "shite or get of the pot", so to speak.
A couple of thought s moving forward.
Cheers